The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
Optimizing Immunosuppression Adherence to Improve Long-term Graft Function
Berlin, Germany / July 15-19, 2012
Berlin - Long-term outcomes following transplantation have improved since the early 1980s but challenges remain, including increasing recipient and donor age as well as growing use of expanded criteria donors, all of which impact graft...
Evaluating Strategies to Extend and Maximize Patient and Graft Survival
Boston, Massachusetts / June 2-6, 2012
Boston - For initial maintenance therapy following transplantation, guidelines recommend first-line use of calcineurin inhibitors (CNIs) with an antiproliferative agent, with or without steroids. However, experts now strive to achieve...
PRIORITY PRESS - 18th Annual International Congress of the International Liver Transplantation Society
Simultaneous Antiviral and Immunosuppressive Treatment Strategies in Liver Transplantation
San Francisco, California / May 16-19, 2012
San Francisco - Long-term outcome of patients undergoing liver transplantation as a result of the complications of hepatitis C viral (HCV) infection is predicted to improve with studies demonstrating that immunosuppressive drugs can be used...
PHYSICIAN PERSPECTIVE - Viewpoint based on presentations from the 15th Congress of the European Society for Organ Transplantation
Improving Long-term Renal Graft Survival
Glasgow, UK / September 4-7, 2011
Reviewed and edited by: Jeffrey S. Zaltzman, MD, FRCPC Director, Renal Transplant, St. Michael’s Hospital, Associate Professor of Medicine, Division of Nephrology, University of Toronto, Toronto, Ontario Causes of Graft...
Simplifying Immunosuppression for Liver Transplant Recipients: A Lifelong Commitment to Optimize Patient and Graft Survival
Valencia, Spain / June 22-25, 2011
Valencia - Following organ transplantation, anti-rejection drug efficacy is critical to optimal patient and graft survival but so, too, are tolerability and ease of administration. The calcineurin inhibitors (CNIs) have a long track record...
Increasing Response and Reducing Adverse Events: An Exploration of Dosing Schedules and Combination Therapies for Multiple Myeloma
Paris, France / May 3-6, 2011
Paris - Proteasome inhibitor-containing regimens have improved response rates and response duration across all disease stages of multiple myeloma (MM) in transplant-eligible and -ineligible patients. New data presented here at the Myeloma...
Simplifying Immunosuppression Regimens Post-Transplantation
Philadelphia, Pennsylvania / April 30-May 4, 2011
Incremental Gains in Renal Transplantation Organ transplantation, made possible by effective strategies to prevent rejection, has been one of the major success stories in medicine over the past several decades. Due to incremental...
Stem Cell Transplantation: Prevention of Invasive Fungal Infections with Primary and Secondary Prophylaxis
Paris, France / April 3-6, 2011
In the early 1990s, allogeneic stem cell transplantation (SCT) recipients experienced improved survival with anti-Candida prophylaxis. However, the medical community observed a subsequent increase in mould infections, most notably invasive...
Perspective on Once-daily Immunosuppressive Therapy
Vancouver, British Columbia / August 15-19, 2010
Vancouver - Following organ transplantation, monitoring for optimal drug blood levels of immunosuppressive therapy is important, as lower levels may reduce efficacy while peaks in drug levels may carry an increased risk of toxicity. While a...